Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version v3.3.4 appears in the page history, replacing v3.3.3. This is a minor site revision and does not modify study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-01-14T02:48:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T17:32:57.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Record history shows a new revision v3.3.2 was added and revision v3.2.0 was removed from the NCT02676869 record, indicating a minor maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:45:40.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The government operating status notice about funding has been removed. All other study history content remains unchanged.
    Difference
    0.7%
    Check dated 2025-11-17T14:59:27.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The Record History shows a minor update to the version list, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:28:14.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.
    Difference
    12%
    Check dated 2025-10-05T10:17:06.000Z thumbnail image

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.